{"id":766763,"date":"2023-06-28T16:11:57","date_gmt":"2023-06-28T20:11:57","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/"},"modified":"2023-06-28T16:11:57","modified_gmt":"2023-06-28T20:11:57","slug":"phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/","title":{"rendered":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <strong>P<\/strong><br \/>\n        <strong>haxiam<\/strong><br \/>\n        <strong> Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <strong>Lyon (France) and Cambridge (MA, US), June 28, 2023 &#8211; Phaxiam Therapeutics (Nasdaq &amp; Euronext: FR0011471135), announces change of the mnemonic code of its share <\/strong><br \/>\n        <strong>from <\/strong><br \/>\n        <strong>ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023.<\/strong>\n      <\/p>\n<ul type=\"square\">\n<li style=\"text-align:justify\">Company name: Phaxiam Therapeutics<\/li>\n<li>ISIN code: FR0011471135<\/li>\n<li style=\"text-align:justify\">\n          <strong>Mnemonic: PHXM<\/strong>\n        <\/li>\n<li style=\"text-align:justify\">Listing: Euronext Paris (Compartment C) and Nasdaq<\/li>\n<\/ul>\n<p align=\"justify\">\n        <strong>About PHAXIAM Therapeutics<\/strong>\n      <\/p>\n<p align=\"justify\">\n        <em>PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM is developing a portfolio of phages targeting 3 of the most resistant and dangerous bacteria, which together account for more than two-thirds of resistant hospital-acquired infections: Staphylococcus aureus, Escherichia coli and Pseudomonas aeruginosa. <\/em>\n      <\/p>\n<p align=\"justify\">\n        <em>PPHAXIAM is listed on the Nasdaq Capital Market in the United States (ticker: PHXM) and on the Euronext regulated market in Paris (ISIN code: FR0011471135, ticker: PHXM). PHAXIAM is part of the CAC Healthcare, CAC Pharma &amp; Bio, CAC Mid &amp; Small, CAC All Tradable, EnterNext PEA-PME 150 and Next Biotech indexes.<\/em>\n      <\/p>\n<p>\n        <em>For more information, please visit <\/em><br \/>\n        <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MqKgkAefqM6yirnF9BJfD3glidQLomq3kFCFD1M3e1UObGaNfSt_DSC0DjhntQwT3Y_-HvszJjHY3c7EEJyFEQ==\" rel=\"nofollow noopener\" target=\"_blank\"><br \/>\n          <em>www.erytech.com<\/em><br \/>\n        <\/a>\n      <\/p>\n<p align=\"justify\">\n        <strong>Contacts<\/strong>\n      <\/p>\n<table style=\"border-collapse: collapse;border-collapse:collapse\">\n<tr>\n<td style=\"width:302.07px;text-align: justify;vertical-align: middle;vertical-align: top\">\n            <strong>PHAXIAM<\/strong><br \/>\n            <br \/>\n            <strong>Eric Soyer<\/strong><br \/>\n            <br \/>COO &amp; CFO<br \/>+33 4 78 74 44 38 <br \/><a href=\"mailto:investors@erytech.com\" rel=\"nofollow noopener\" target=\"_blank\">investors@erytech.com<\/a><\/p>\n<\/td>\n<td style=\"width:302.07px;vertical-align: top\">\n            <strong>NewCap<\/strong><br \/>\n            <br \/>\n            <strong>Mathilde Bohin \/ Louis-Victor Delouvrier <\/strong><br \/>\n            <br \/>Relations investisseurs<br \/><strong>Arthur Rouill\u00e9<\/strong><br \/>Relations Me\u0301dias <br \/>+33 1 44 71 94 94 <br \/><a href=\"mailto:phaxiam@newcap.eu\" rel=\"nofollow noopener\" target=\"_blank\">phaxiam@newcap.eu<\/a><\/td>\n<\/tr>\n<\/table>\n<p>\u00a0<\/p>\n<p id=\"gnw_attachments_section-header\">\n        <strong>Attachment<\/strong>\n      <\/p>\n<ul id=\"gnw_attachments_section-items\">\n<li>\n          <a target=\"_blank\" href=\"https:\/\/ml-eu.globenewswire.com\/Resource\/Download\/d07bc7ca-0fe7-4854-baa2-38b9429d7f60\" rel=\"noopener\">PR_PHAXIAM_Mn\u00e9mo_062823_EN<\/a>\n        <\/li>\n<\/ul>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml-eu.globenewswire.com\/media\/MDAwNmNiM2EtYWEzZC00NDMwLWEyOWUtZDI0M2I0ZGYzMTViLTEwMzE4MDQ=\/tiny\/Erytech-Pharma-S-A-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>P haxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM Lyon (France) and Cambridge (MA, US), June 28, 2023 &#8211; Phaxiam Therapeutics (Nasdaq &amp; Euronext: FR0011471135), announces change of the mnemonic code of its share from ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023. Company name: Phaxiam Therapeutics ISIN code: FR0011471135 Mnemonic: PHXM Listing: Euronext Paris (Compartment C) and Nasdaq About PHAXIAM Therapeutics PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-766763","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"P haxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM Lyon (France) and Cambridge (MA, US), June 28, 2023 &#8211; Phaxiam Therapeutics (Nasdaq &amp; Euronext: FR0011471135), announces change of the mnemonic code of its share from ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023. Company name: Phaxiam Therapeutics ISIN code: FR0011471135 Mnemonic: PHXM Listing: Euronext Paris (Compartment C) and Nasdaq About PHAXIAM Therapeutics PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM &hellip; Continue reading &quot;Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-06-28T20:11:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM\",\"datePublished\":\"2023-06-28T20:11:57+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/\",\"name\":\"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==\",\"datePublished\":\"2023-06-28T20:11:57+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/","og_locale":"en_US","og_type":"article","og_title":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM - Market Newsdesk","og_description":"P haxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM Lyon (France) and Cambridge (MA, US), June 28, 2023 &#8211; Phaxiam Therapeutics (Nasdaq &amp; Euronext: FR0011471135), announces change of the mnemonic code of its share from ERYP to PHXM, following the merger between ERYTECH and PHERECYDES. The change has been notified by Euronext and will be effective from June 29, 2023. Company name: Phaxiam Therapeutics ISIN code: FR0011471135 Mnemonic: PHXM Listing: Euronext Paris (Compartment C) and Nasdaq About PHAXIAM Therapeutics PHAXIAM is a biopharmaceutical company developing innovative treatments for resistant bacterial infections, which are responsible for many serious infections. The company is building on an innovative approach based on the use of phages, natural bacterial-killing viruses. PHAXIAM &hellip; Continue reading \"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/","og_site_name":"Market Newsdesk","article_published_time":"2023-06-28T20:11:57+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM","datePublished":"2023-06-28T20:11:57+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/","name":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==","datePublished":"2023-06-28T20:11:57+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=MTAwMDgyNzQ4NyM0MDE1NzQ0ODYjMjAyMDIzMg=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/phaxiam-therapeutics-announces-its-new-mnemonic-code-on-euronext-and-nasdaq-phxm\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Phaxiam Therapeutics announces its new mnemonic code on Euronext and Nasdaq: PHXM"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/766763","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=766763"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/766763\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=766763"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=766763"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=766763"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}